Defining the Epidemiology of Covid-19 - Studies Needed.

• Type of Material: Article
• Authors: Marc Lipsitch, Harvard T.H. Chan School of Public Health; David Swerdlow, Emory University; Lyn Finelli, Merck Research Laboratories
• Language: English
• Date: 2020-02-19
• Publisher: Massachusetts Medical Society
• Publication Version: Final Published Version
• Copyright Statement: © 2020 Massachusetts Medical Society. All rights reserved.
• Final Published Version (URL): http://dx.doi.org/10.1056/NEJMp2002125
• Title of Journal or Parent Work: New England Journal of Medicine
• ISSN: 0028-4793
• Keywords: Covid-19; pandemic; 2019 Novel Coronavirus; China; Wuhan
• Research Categories: Biology, Virology

Abstract

The epidemic of 2019 novel coronavirus (now called SARS-CoV-2, causing the disease Covid-19) has expanded from Wuhan throughout China and is being exported to a growing number of countries, some of which have seen onward transmission. Early efforts have focused on describing the clinical course, counting severe cases, and treating the sick. Experience with the Middle East respiratory syndrome (MERS), pandemic influenza, and other outbreaks has shown that as an epidemic evolves, we face an urgent need to expand public health activities in order to elucidate the epidemiology of the novel virus and characterize its potential impact. The impact of an epidemic depends on the number of persons infected, the infection’s transmissibility, and the spectrum of clinical severity.